Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Ever get the feeling that:

<< Previous

Bullboard Posts

Next >>

Comment by Lesalpes29on Nov 30, 2022 5:52am

147 Views

Post# 35138815

RE:RE:RE:RE:RE:RE:RE:RE:RE:Ever get the feeling that:

TitanBrawler wrote: There is no offer in the near future.
If the drug works it wouldn't be sitting at 2 bucks.
The only thing that's real is the pumpers making everyone believe in a fairly tail.

When onc hit $2.60 last week.. who do you think sold and bought back at $1.90.
(I won't mention any names).
These pumpers are day trading with your money and making a good living.-
They have been pumping and dumping for years
Easy money for doing nothing and laughing all the way to the bank.

m MoronBrawler is back, listen to him he knows everything about this little biotech... even what is going on behind the scene. I will keep my shares in case he is wrong!

<< Previous

Bullboard Posts

Next >>

First Nations contributions attract investor interest